Help Move Georgia Forward
Brian Kemp’s campaign is once again facing allegations of “pay to play” and shady fundraising practices. Last night, new reporting from 11Alive revealed that Kemp took a total of $301,400 in campaign cash from two donors before appointing them to Georgia’s powerful Board of Regents.
Watch: Kemp names big political donors to Board of Regents
The new report comes after an investigation last month from FOX 5 Atlanta revealed Kemp took $50,000 from the CEO of a medical marijuana company shortly after the company was chosen by the Access to Medical Marijuana Commission (whose members were selected by the Governor, Lt. Governor, and Speaker of the House) as one of the six to grow and sell medical marijuana in Georgia.
The contributions were made to Kemp’s Georgians First Leadership Committee, which was created after he signed a bill in secret to create the committee and give himself an exclusive vehicle to raise unlimited campaign cash. In doing so, Kemp not only gave himself an unfair advantage against opponents on both sides of the aisle, but also provided himself a loophole from a thirty-year old ethics law prohibiting fundraising during the legislative session.
A Continued Pattern: In 2018, an AJC investigation found that Kemp accepted over $325,000 in contributions from entities under his oversight as Secretary of State, and noted that “the legality of some of these donations is in question.” Exactly how much Kemp raked in is unknown because he failed to properly fill out his disclosure, leaving out critical information for almost 40% of his donors. At the time, critics said “such donations could undermine the credibility of one of the state’s top regulators,” and two previous secretaries of state said they returned similar donations to comply with the law and avoid the appearance of a conflict of interest.
Read more on Brian Kemp’s “pay to play” campaign fundraising below:
11Alive: Kemp names big political donors to Board of Regents
###
September 11, 2024
September 11, 2024
September 4, 2024